Envoy Medical Enters Material Definitive Agreement
Ticker: COCHW · Form: 8-K · Filed: Dec 29, 2025 · CIK: 1840877
Sentiment: neutral
Topics: material-agreement, corporate-action
TL;DR
Envoy Medical just signed a big deal, filing an 8-K on Dec 18, 2025.
AI Summary
Envoy Medical, Inc. reported on December 18, 2025, entering into a material definitive agreement. The filing also includes financial statements and exhibits related to this agreement. The company, previously known as Anzu Special Acquisition Corp I, is incorporated in Delaware and operates in the orthopedic, prosthetic & surgical appliances & supplies industry.
Why It Matters
This filing indicates a significant new contract or partnership for Envoy Medical, which could impact its future revenue and operational strategy.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities, the specifics of which are not detailed in this initial filing.
Key Players & Entities
- Envoy Medical, Inc. (company) — Registrant
- Anzu Special Acquisition Corp I (company) — Former company name
- December 18, 2025 (date) — Date of earliest event reported
- December 29, 2025 (date) — Filing date
FAQ
What is the nature of the material definitive agreement entered into by Envoy Medical, Inc.?
The filing does not specify the details of the material definitive agreement, only that one was entered into on December 18, 2025.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on December 18, 2025.
What was Envoy Medical, Inc.'s former name?
Envoy Medical, Inc.'s former name was Anzu Special Acquisition Corp I.
In which state is Envoy Medical, Inc. incorporated?
Envoy Medical, Inc. is incorporated in Delaware.
What is Envoy Medical, Inc.'s primary business sector?
Envoy Medical, Inc. operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector.
Filing Stats: 708 words · 3 min read · ~2 pages · Grade level 12 · Accepted 2025-12-29 16:01:27
Key Financial Figures
- $0.0001 — tered Class A Common Stock, par value $0.0001 per share COCH The Nasdaq Stock Mar
- $11.50 — A Common Stock at an exercise price of $11.50 per share COCHW The Nasdaq Stock Ma
- $1.50 — ekly, and subject to a minimum price of $1.50 per share. The issuance and resale of
Filing Documents
- ea0270888-8k_envoy.htm (8-K) — 43KB
- ea027088801ex10-1_envoy.htm (EX-10.1) — 19KB
- 0001213900-25-126032.txt ( ) — 271KB
- coch-20251218.xsd (EX-101.SCH) — 4KB
- coch-20251218_def.xml (EX-101.DEF) — 26KB
- coch-20251218_lab.xml (EX-101.LAB) — 36KB
- coch-20251218_pre.xml (EX-101.PRE) — 25KB
- ea0270888-8k_envoy_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 29, 2025 ENVOY MEDICAL, INC. By: /s/ Brent Lucas Brent Lucas Chief Executive Officer 2